Abstract
OBJECTIVE: To assess whether the −455 and −482 mutations in APOC-III gene insulin response element affect the relationships between plasma insulin and triglyceride-rich lipoprotein levels.
DESIGN: Population-based studies.
SUBJECTS: The population sample was composed of 983 subjects (485 men and 498 women), aged between 35 and 65 y, randomly sampled from the electoral rolls in Northern France and stratified on gender and 10 y age groups.
MEASUREMENTS: Plasma triglyceride, apolipoprotein C-III, apoB, LpC-III:B and LpE:B lipoprotein particles and insulin levels were measured. Two polymorphisms in APOC-III gene insulin response element (T→C at −455 and/or C→T at −482) were determined.
RESULTS: Plasma insulin was positively correlated to triglyceride levels (P<0.0001), apo C-III (P<0.003), LpC-III:B (P<0.0001), apoB (P<0.0001) and LpE:B (P<0.0001). This association differed significantly according to APOC-III insulin response element polymorphisms. The relationship between insulin and LpC-III:B (P<0.02) or apoB (P<0.02) was greater in women bearing the C allele of −455 than the T allele. Similarly, the relationship between insulin and LpC-III:B (P<0.02) or LpE:B (P<0.05) was greater in women bearing the T allele of −482 than the C allele. There was no evidence for any effect in men.
CONCLUSION: These results suggest that the relationship between plasma insulin and triglyceride-rich lipoprotein levels is partly influenced by polymorphisms in APOC-III insulin response element.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Steiner G . Hyperinsulinaemia and hypertriglyceridaemia J Intern Med Suppl 1994 736: 23–26.
Lewis GF, Zinman B, Uffelman KD, Szeto L, Weller B, Steiner G . VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin Am J Physiol 1994 267: E566–E572.
Steiner G, Haynes FJ, Yoshino G, Vranic M . Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics Am J Physiol 1984 246: E187–E192.
Laws A . Free fatty acids, insulin resistance and lipoprotein metabolism Curr Opin Lipidol 1996 7: 172–177.
Ginsberg HN . Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis Diabetes Care 1991 14: 839–855.
Shimada M, Ishibashi S, Gotoda T, Kawamura M, Yamamoto K, Inaba T, Harada K, Ohsuga J, Perrey S, Yazaki Y . Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia Arterioscler Thromb Vasc Biol 1995 15: 1688–1694.
Chen M, Breslow JL, Li W, Leff T . Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels J Lipid Res 1994 35: 1918–1924.
Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T . Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. [See comments.] J Clin Invest 1995 96: 2601–2605.
Wang CS, McConathy WJ, Kloer Hu, Alaupovic P . Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III J Clin Invest 1985 75: 384–390.
Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL . Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles J Clin Invest 1992 90: 1889–1900.
Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J . Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia J Biol Chem 1994 269: 23610–23616.
Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL . An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms Proc Natl Acad Sci USA 1993 90: 4562–4566.
Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A . Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents Circulation 1994 90: 583–612.
Helbecque N, Dallongeville J, Codron V, Arveiler D, Ruidavets JB, Evans A, Cambien F, Fruchart JC, Amouyel P . The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humans Arterioscler Thromb Vasc Biol 1997 17: 2759–2764.
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16: 1215.
Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N . Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia Science 1985 230: 1350–1354.
Dallongeville J, Meirhaeghe A, Cottel D, Fruchart JC, Amouyel P, Helbecque N . Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France Atherosclerosis 2000 150: 149–157.
Kee F, Amouyel P, Arveiler D, Cambou JP, Ducimetiere P, Evans A, Fruchart JC, Cambien F, Dallongeville J . Lack of association between genetic variations of apo A-1, C-III, A-IV gene cluster and myocardial infarction in a sample of European males: ECTIM study Atherosclerosis 1999 145: 187–195.
Peacock RE, Temple A, Gudnason V, Rosseneu M, Humphries SE . Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status Genet Epidemiol 1997 14: 265–282.
Porkka KV, Taimela S, Kontula K, Lehtimaki T, Aalto-Setala K, Akerblom HK, Viikari JS . Variability gene effects of DNA polymorphisms at the apo B, apo A I/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study Clin Genet 1994 45: 113–121.
Kessling A, Ouellette S, Bouffard O, Chamberland A, Betard C, Selinger E, Xhignesse M, Lussier-Cacan S, Davignon J . Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones Am J Hum Genet 1991 50: 92–106.
Xu CF, Angelico F, Del Ben M, Humphries S . Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls Genet Epidemiol 1993 10: 113–122.
Anderson RA, Burns TL, Lee J, Swenson D, Bristow JL . Restriction fragment length polymorphisms associated with abnormal lipid levels in an adolescent population Atherosclerosis 1989 77: 227–237.
Haviland MB, Kessling AM, Davignon J, Sing CF . Cladistic analysis of the apolipoprotein AI-CIII-AIV gene cluster using a healthy French Canadian sample. I. Haploid analysis Ann Hum Genet 1995 59: 211–231.
Dallongeville J, Bauge E, Lebel P, Fruchart JC . Fat ingestion is associated with increased levels of apoC-III- and apoE- B-containing lipoprotein particles in humans Eur J Clin Invest 1997 27: 1055–1060.
Alaupovic P . Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families Prog Lipid Res 1991 30: 105–138.
Kandoussi A, Cachera C, Parsy D, Bard JM, Fruchart JC . Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay: apo B with apo C-III and apo B with apo E J Immunoassay 1991 12: 305–323.
Clavey V, Lestavel-Delattre S, Copin C, Bard JM, Fruchart JC . Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E Arterioscler Thromb Vasc Biol 1995 15: 963–971.
Agnani G, Bard JM, Candelier L, Delattre S, Fruchart JC, Clavey V . Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells Arterioscler Thromb 1991 11: 1021–1029.
Lussier-Cacan S, Bard JM, Boulet L, Nestruck AC, Grothe AM, Fruchart JC, Davignon J . Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III Atherosclerosis 1989 78: 167–182.
Alaupovic P, McConathy WJ, Fesmire J, Tavella M, Bard JM . Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias Clin Chem 1988 34: B13–B27.
Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B . Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians Arterioscler Thromb Vasc Biol 1997 17: 1060–1066.
Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B . Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins Arterioscler Thromb Vasc Biol 1997 17: 2753–2758.
Surguchov AP, Page GP, Smith L, Patsch W, Boerwinkle E . Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia Arterioscler Thromb Vasc Biol 1996 16: 941–947.
Shoulders CC, Grantham TT, North JD, Gaspardone A, Tomai F, de Fazio A, Versaci F, Gioffre PA, Cox NJ . Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children Hum Genet 1996 98: 557–566.
Acknowledgements
The authors wish to thank Mrs V Codron, Mr X Hermant, Mr Eric Baugé for technical assistance. Mrs A Meirhaeghe was supported by a grant from the Ministère de I'Enseignement Supérieur et de la Recherche. The WHO-MONICA population study developed in the North of France was supported by unrestricted grants from the Conseil Régional du Nord-Pas de Calais, ONIVINS, Parke-Davies Laboratory, the Mutuelle Généale de I'Education Nationale (MGEN), Groupe Fournier, the Réseau National de Santé Publique, the Direction Générale de la Santé, the Institut National de la Santé Et de la Recherche Médicale (INSERM), the Institut Pasteur de Lille and the Unité d'Evaluation du Centre Hospitalier et Universitaire de Lille.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dallongeville, J., Meirhaeghe, A., Cottel, D. et al. Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans. Int J Obes 25, 1012–1017 (2001). https://doi.org/10.1038/sj.ijo.0801658
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801658
Keywords
This article is cited by
-
Effect of the APOC3 Sst I SNP on fasting triglyceride levels in men heterozygous for the LPL P207L deficiency
European Journal of Human Genetics (2005)
-
Population prevalence of APOE, APOC3 and PPAR-α mutations associated to hypertriglyceridemia in French Canadians
Journal of Human Genetics (2004)